American Health News and
Wellness Report Newsletter
 
Prevention is a Cure (c)  
FEBRUARY  2011 - Vol 12 Issue 6

AHA Masthead HeartLumosity logo 

In This Issue
ATTACK CLOSTRIDIUM DIFFICILE
PREDICTING HEART ATTACKS
HIGHER CANCER RISK AFTER CARDIAC TESTS
Join Our Mailing List!
Quick Links
Greetings!
Calendar of events
 
 
Saturday, February 19th 2011  8pm
An American Health Fun Raiser on behalf of the
American Volunteer Corps and the Orphans of War Campaign
  
  
Call the American Health Association for any special offering.
President American Health Association
J. Robert Gordon
Attacks Clostridium Difficile
 

New Drug Attacks Clostridium Difficile

(American Health  Newswire) -- Nausea, diarrhea, and abdominal pain. Every year, tens of thousands of people in the United States get sick from Clostridium difficile (CDI), but new research shows a new antibiotic could help fight against the spread of this nasty stomach bug.

 

CDI can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon. In recent years, CDI infections have become more frequent and more difficult to treat. Recent studies show the disease is killing more and more patients each year.

 

Current treatments for CDI infection have been inadequate. The bug is commonly treated with Vancomycin, but nearly one in three patients who recover from a CDI infection suffers a relapse within 30 days. This high relapse rate contributes to hospital outbreaks, as many patients have to return to the hospital for treatment.

 

For this study, researchers tested out a new drug called Fidaxomicin. Researchers studied 629 patients with CDI infections. Half of the patients received the new drug, and the other half received Vancomycin. Researchers reported that about 88 percent of those treated with Fidaxomicin and 85 percent of those treated with Vancomycin were cured. However, significantly fewer patients taking the new antibiotic had a recurrence of infection compared to those taking Vancomycin.

 

"The most exciting aspect of this research is the ability of the new medication, Fidaxomicin, to reduce the recurrent rate of CDI by almost half.  No treatment of CDI has been able to reduce the recurrence rate, until now. Recurrences of CDI are a huge burden to the patient, their caregiver, and to the hospitals," Dr. Mark A. Miller, study co-author, and Head of the Division of Infectious Diseases at the Jewish General Hospital in Montreal, told American Health.

 

Dr. Miller added that Fidaxomicin is not presently available on the market, but the FDA is expected to make a decision on whether or not to approve the drug in May. If approved, the medication could be available in the United States towards the end of 2011.

 

.SOURCE: NEJM, February 3, 2011 

 

Predicting Heart Attacks

NASHVILLE, TN (American Health  Newswire) -- Every 35 seconds, an American dies of heart disease. If your family has a history of heart attacks or stroke, you are twice as likely to have one yourself. Now, for the first time in medical history, two tests can predict if your genes are putting you at risk.

 

Three people, one thing in common: heart disease has killed members of their family.

 

"In the back of my mind, I feel like I'm a little ticking time bomb," Holly Roche, 45 years old, told American Health.

 

 

The odds are not in Roche's favor. She knows her DNA puts her at risk. But what she didn't know -- genes change over time and so can her risk of a heart attack.

 

"When somebody is healthy, you may not have an expression of certain genes, but when you're sick, you may get an increased level of a certain gene," John A. McPherson, M.D., FACC, FAHA, Cardiologist at Vanderbilt Heart and Vascular Institute in Nashville, TN, said.

 

 

Dr. McPherson is one of the first doctors in the country to give a one of its kind blood test that reads a person's genomic expression.

 

"What this test does is measures the levels of different genes that can change over time," Dr. McPherson explained.

 

 

Forty-three year old Larissa Jennings has been feeling tightness in her chest. Her mother, father and grandmother all died from heart disease.


"You can see, I'm a fluffy person as my family would say," Larissa Jennings, 43 years old, stated.

 

 

"It's very important that we make sure she's not suffering from coronary artery disease," Dr. McPherson added.

 

The test measures 23 different genes, focusing on the white blood cells. They're called inflammatory cells because they're activated when plaque builds up in the arteries. Measurements under 25 percent: low risk.

 

 

Above 50 percent: high risk. Jennings's results: she had an eight percent likelihood of obstructive disease. Roche's risk: low as well. But this test is for folks who feel out of sorts or have chest pains. What about catching heart failure before the signs kick in?

 

"I do something every day. Walk. Tennis doubles. I'm a kayaker, and I have a single kayak," Edith Donohue, 72 years old, said.

 

  

A lifestyle that helps reduce Donohue's risk of heart failure, but that's not enough for her.

 

Doctor Christopher deFilippi of the University of Maryland School of Medicine and his team studied a blood test to see what it would reveal in blood samples that were taken over time.

 

"We found, with this test, two-thirds of older adults in the community had detectable levels," Christopher deFilippi, M.D., Associate Professor at the University of Maryland School of

Medicine, explained.

 

A highly sensitive version of a cardiac test called Troponin measures Troponin T -- a marker for the process of cell death that causes heart failure. As Troponin levels rise in the blood, so does the risk of heart failure symptoms and death from cardiovascular disease over the next 10 to 15 years.

 

"It's a great sense of relief," Jennings stated.

 

"Every time I feel a little twinge, extra beat or skipped beat, I don't go, 'oh my gosh,' because I don't think there's anything wrong with me," Roche concluded.

 

 

Two discoveries that could someday alert millions of people who are unknowingly at risk.

Higher Cancer Risk after Cardiac Tests

Higher Cancer Risk After Cardiac Tests

(American Health Newswire) -- Cardiac imaging tests, such as CT scans could be putting heart attack patients at a higher risk of cancer.

 

According to a new study, exposure to low-dose radiation is associated with an increased risk of cancer. Typically, the amount of radiation that patients are exposed to is so small that it doesn't pose a major health risk, but when there are multiple scans the damage can start to add up.

 

Patients with known or suspected coronary artery disease, tend to have more frequent exposures to low-dose radiation procedures. In many places, radiation procedures are replacing non-radiation procedures like stress tests on exercise treadmills and echocardiography (a sonogram of the heart).

 

Between 1996 and 2006 researchers at MUHC and the Jewish General Hospital in Montréal examined 82,861 heart attack patients who had no history of cancer. Seventy-seven percent underwent at least one cardiac procedure that exposed them to low-dose radiation within a year of the attack. Patients who were treated by a cardiologist had higher levels of exposure to radiation compared with those who were treated by a general practitioner. The findings showed about 12,000 incident cancers detected during follow up, and two-thirds of the cancers affected the abdomen and chest areas.

 

"These results call into question whether our current enthusiasm for imaging and therapeutic procedures after acute myocardial infarction should be tempered. We should at least consider putting into place a system of prospectively documenting the imaging tests and procedures that each patient undergoes and estimating his or her cumulative exposure to low-dose ionizing radiation," the authors were quoted as saying. 

 

The authors say the best solution may be using procedures with lower or no radiation exposure, especially if there are multiple procedures involved.

 SOURCE: CMAJ, February 7, 2011


100% of every dollar goes to service the charities programs and services here in Palm Beach County and around the globe Not one cent in 8 years has ever gone to salaries, of any kind, to anyone. We are, from top to bottom all volunteers in service to the community.
MISSION STATEMENT
The American Health Society is a distinguished 11 year old multi-award winning preventative public health & wellness 501(c)(3) charity whose mission is in preventative healthcare, mental wellness, health education, literacy and advocacy aimed at preventing lifestyle based illnesses, diseases and the frailties of aging. 
 
We have a strong "Social Green Philosophy" of Humanitarian  Service through our American Volunteer Corps which has a global outreach in 46 countries with members in 37 US States.

J. Robert Gordon - CEO and Founder
American Health Association
561-361-9091
Newsletter Editor and Communications Manager:
Suzanne Parent - suzanne@americanhealthfoundation.com